TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Holders of 5% or more of HURA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TuHURA Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 13G | 5.11%2.23M shares | New | Jul 29, 20251 filing | Jul 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on TuHURA Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20255:05 PM ET | KP Biotech Group LLC | 13G/A | 0.90%447.2K shares | –Below 5% | Jun 12, 2025 | SEC |
| Aug 14, 20255:01 PM ET | CA Patel F&F Investments, LLC | 13G/A | 0.90%447.2K shares | –Below 5% | Jun 12, 2025 | SEC |
| Jul 29, 20252:49 PM ET | Vanguard Group Inc | 13G | 5.11%2.23M shares | New | Jun 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell TuHURA Biosciences, Inc. shares.
No Form 144 notices for TuHURA Biosciences, Inc. are on file.